Mercaptoamide compounds, represented by Formulas (IA), (IB), (IIA), and (IIB):
or a pharmaceutically acceptable salt thereof, inhibit histone deacetylase enzyme and are useful for the treatment and/or prevention of various infections, cancerous diseases, and conditions.
Provided is a method for the functionalization of immunoglobulins through the use of transglutaminase, including methods for screening functionalized antibodies for characteristics of interest, antibody compositions comprising a plurality of functionalized antibodies, and functionalized antibodies with rodent constant regions.
[EN] RECOGNITION TAGS FOR TGASE-MEDIATED CONJUGATION<br/>[FR] ETIQUETTES DE RECONNAISSANCE POUR LA CONJUGAISON À MÉDIATION PAR LA TGASE
申请人:INNATE PHARMA
公开号:WO2014072482A1
公开(公告)日:2014-05-15
The present application relates to methods for the functionalization of antibodies using transglutaminase, in particular antibodies lacking Fc regions. Also disclosed herein are peptide tags for transglutaminase, linking reagents, functionalized antibodies, multi-specific antibodies, pharmaceutical compositions, and method of treating disease and/or conditions.
[EN] MERCAPTOAMIDES AS HISTONE DEACETYLASE INHIBITORS<br/>[FR] MERCAPTOAMIDES EN TANT QU'INHIBITEURS D'HISTONE DEACETYLASE
申请人:OSI PHARM INC
公开号:WO2006028972A2
公开(公告)日:2006-03-16
Mercaptoamide compounds, represented by Formulas (IA), (IB), (IIA), and (IIB): or a pharmaceutically acceptable salt thereof, inhibit histone deacetylase enzyme and are useful for the treatment and/or prevention of various infections, cancerous diseases, and conditions.